Buy Sujana Towers, target of Rs 202: Religare

Published on Fri, Jun 20, 2008 at 16:17 |  Source : Moneycontrol.com

Updated at Fri, Jun 20, 2008 at 16:21  

4616 Investors following Sujana Towers. Share this News with them.
0
0
Share on Tumblr

RELATED NEWS

Religare Research has recommended a buy rating on Sujana Towers with a target price of Rs 202 in its June 16, 2008 research report. "Augmenting capacity at its Chennai plant by 100,000MT, taking total production to 228,000MT. Project funding fully tied up with operations on schedule to commence in September. The company expects to record a turnover of Rs 3 billion from Chennai in FY09 and Rs 4 billion in FY10. We expect the operating margin to be maintained at 15.5-16% owing to backward integration initiatives and entry into power transmission. Revenue and PAT estimated to grow at 31% and 44% CAGR respectively over FY08-FY10."

"Currently trades at a P/E of 6.4x and 4.5x on FY09E and FY10E FDEPS. The stock has corrected significantly post-January and offers an attractive entry point for investment," says Religare's research report.

Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
 
For further details click on attachment.......

  

More on Moneycontrol

Trending News

Business News

Ice Cream Sandwich ported to Nokia N9
Forget the IIP: there's free cash oozing out of every pore "Forget the IIP: there's free cash oozing out of every pore "

DLF Says Macro Environment Unfavourable W/High Comm & Labour Inflation

The latest earning numbers FIRST on CNBC-TV18
Videos

Feb 10 2012, 21:39

Tulsian buys steel stocks; negative on sugar, ADAG

- in MARKET OUTLOOK

Feb 10 2012, 21:39

Truck demand sluggish; margins down 80bps: Shriram Trans

- in Results Boardroom

Interviews

Feb 10 2012, 15:43 | Source: CNBC-TV18

Growth in margins sustainable going forward: Shasun Pharma  

Feb 10 2012, 15:35 | Source: CNBC-TV18

Expect Q4 GRMs to be similar to Q3: BPCL  

Subscribe to

Moneycontrol Newsletters

Moneycontrol.com offers you a choice of various sectoral and other newsletters for FREE!

Follow moneycontrol.com